Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Alexander

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
United European Gastroenterology Journal|March 8, 2018
Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic diseaseMartha M Kirstein, Torsten Voigtländer, Nora Schweitzer, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionEric Lawitz, Robert Flisiak, Manal Abunimeh, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Infectious Diseases of Poverty|August 21, 2019
Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men in China: a study protocol for a three-arm cluster randomized controlled trialTiange P Zhang, Fan Yang, Weiming Tang, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
United European Gastroenterology Journal|March 8, 2018
Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic diseaseMartha M Kirstein, Torsten Voigtländer, Nora Schweitzer, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionEric Lawitz, Robert Flisiak, Manal Abunimeh, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Infectious Diseases of Poverty|August 21, 2019
Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men in China: a study protocol for a three-arm cluster randomized controlled trialTiange P Zhang, Fan Yang, Weiming Tang, et al.
Pageof 14